AU4961499A - 5-HT1f agonists - Google Patents
5-HT1f agonistsInfo
- Publication number
- AU4961499A AU4961499A AU49614/99A AU4961499A AU4961499A AU 4961499 A AU4961499 A AU 4961499A AU 49614/99 A AU49614/99 A AU 49614/99A AU 4961499 A AU4961499 A AU 4961499A AU 4961499 A AU4961499 A AU 4961499A
- Authority
- AU
- Australia
- Prior art keywords
- ht1f agonists
- ht1f
- agonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 239000000556 agonist Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US9087298P | 1998-06-26 | 1998-06-26 | |
| US60090872 | 1998-06-26 | ||
| US9495798P | 1998-07-31 | 1998-07-31 | |
| US60094957 | 1998-07-31 | ||
| PCT/US1999/014502 WO2000000490A2 (en) | 1998-06-26 | 1999-06-24 | 5-ht1f agonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU4961499A true AU4961499A (en) | 2000-01-17 |
Family
ID=26782729
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU49614/99A Abandoned AU4961499A (en) | 1998-06-26 | 1999-06-24 | 5-HT1f agonists |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU4961499A (en) |
| WO (1) | WO2000000490A2 (en) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7211594B2 (en) | 2000-07-31 | 2007-05-01 | Signal Pharmaceuticals, Llc | Indazole compounds and compositions thereof as JNK inhibitors and for the treatment of diseases associated therewith |
| US6897231B2 (en) | 2000-07-31 | 2005-05-24 | Signal Pharmaceuticals, Inc. | Indazole derivatives as JNK inhibitors and compositions and methods related thereto |
| ES2296910T3 (en) | 2001-01-22 | 2008-05-01 | Sankyo Company, Limited | SUBSTITUTED COMPOUNDS WITH AMINO BICICLIC GROUP. |
| MXPA03006776A (en) * | 2001-01-29 | 2003-10-24 | Applied Research Systems | Use of il-18 inhibitors for the treatment and/or prevention of heart disease. |
| CA2440842A1 (en) | 2001-04-16 | 2002-10-24 | Eisai Co., Ltd. | Novel 1h-indazole compounds |
| TWI263497B (en) | 2002-03-29 | 2006-10-11 | Lilly Co Eli | Pyridinoylpiperidines as 5-HT1F agonists |
| CN1777584A (en) | 2003-04-18 | 2006-05-24 | 伊莱利利公司 | (Piperidinyloxy)phenyl, (piperidinyloxy)pyridyl, (piperidinylthio)phenyl and (piperidinylthio)pyridyl compounds as 5-HT1F agonists |
| UA82711C2 (en) | 2003-09-12 | 2008-05-12 | Эли Лилли Энд Компани | Substituted 2-carbonylamino-6-piperidinaminopyridines and substituted 1-carbonylamino-3-piperidinaminobenzenes as 5-ht1f agonists |
| ES2291978T3 (en) | 2003-12-17 | 2008-03-01 | Eli Lilly And Company | COMPOUNDS OF (4-AMINOCICLOHEXEN-1-IL) PHENYL AND (4-AMINOCICLOHEXEN-1-IL) PIRIDINYL SUBSTITUTED AS AGONISTS OF 5-HT1F. |
| HUE037261T2 (en) | 2009-04-02 | 2018-08-28 | Colucid Pharmaceuticals Inc | 2,4,6-trifluoro-n-[6-(1-methyl-piperidin-4-carbonyl)-pyridin-2-yl]-benzamide for the treatment of migraine via the oral or intravenous route |
| CA2795062A1 (en) | 2010-04-02 | 2011-10-06 | Colucid Pharmaceuticals, Inc. | Compositions and methods of synthesis of pyridinoylpiperidine 5-ht1f agonists |
| CN103044316A (en) * | 2013-01-23 | 2013-04-17 | 石家庄学院 | Method for preparing 1,4-dihydropyridine by using imidazole ionic liquid as catalyst |
| TWI826514B (en) | 2018-09-04 | 2023-12-21 | 美商美國禮來大藥廠 | Chronic nightly dosing of lasmiditan for migraine prevention |
| TWI829107B (en) | 2019-07-09 | 2024-01-11 | 美商美國禮來大藥廠 | Processes and intermediate for the large-scale preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide hemisuccinate, and preparation of 2,4,6-trifluoro-n-[6-(1-methyl-piperidine-4-carbonyl)-pyridin-2-yl]-benzamide acetate |
| CN115872916B (en) * | 2022-11-30 | 2025-03-25 | 华东理工大学 | A method for synthesizing indole-5-carboxaldehyde compounds based on microchannel reactor |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8719167D0 (en) * | 1987-08-13 | 1987-09-23 | Glaxo Group Ltd | Chemical compounds |
| GB8724912D0 (en) * | 1987-10-23 | 1987-11-25 | Wellcome Found | Indole derivatives |
| ATE156823T1 (en) * | 1990-06-07 | 1997-08-15 | Zeneca Ltd | THERAPEUTIC HETEROCYCLIC COMPOUNDS |
| GB9226532D0 (en) * | 1992-12-21 | 1993-02-17 | Smithkline Beecham Plc | Compounds |
| ATE144773T1 (en) * | 1993-04-22 | 1996-11-15 | Pfizer Res & Dev | INDOLE DERIVATIVES AS 5-HT1-LIKE ANTAGONISTS FOR THE TREATMENT OF MIGRAINES |
| EP0759918A1 (en) * | 1994-05-19 | 1997-03-05 | MERCK SHARP & DOHME LTD. | Piperazine, piperidine and tetrahydropyridine derivatives of indol-3-ylalkyl as 5-ht1d-alpha agonists |
| US5521197A (en) * | 1994-12-01 | 1996-05-28 | Eli Lilly And Company | 3-<1-alkylenearyl>-4-<1,2,3,6-tetrahydropyridinyl>-and 3-<1-alkylenearyl>-4-piperidinyl-1h-indoles: new 5-HT1F agonists |
| PL322843A1 (en) * | 1995-03-20 | 1998-02-16 | Lilly Co Eli | 5-substituted 3-91,2,3,6-tetrahydropyridin-4-yl)- and 3-9piperydin-4-4-yl0-1h-indoles nevel 5-htif natagonists |
-
1999
- 1999-06-24 AU AU49614/99A patent/AU4961499A/en not_active Abandoned
- 1999-06-24 WO PCT/US1999/014502 patent/WO2000000490A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2000000490A2 (en) | 2000-01-06 |
| WO2000000490A3 (en) | 2003-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU5203999A (en) | Beta3-adrenergic receptor agonists | |
| AU3485999A (en) | Neo-tryptophan | |
| AU9392998A (en) | Pack-a-pillow | |
| AU7128798A (en) | Substituted heteroaromatic 5-ht1f agonists | |
| AU4961499A (en) | 5-HT1f agonists | |
| AU3437799A (en) | City-car | |
| AU3522399A (en) | Carvedilol-galenics | |
| HUP0004317A3 (en) | 5-ht1f agonists | |
| AU5407599A (en) | Sphingolipid-desaturase | |
| AU3253699A (en) | Myxochelines | |
| IL144355A0 (en) | 5-ht1f agonists | |
| AU5516599A (en) | Substituted 3-aryl-pyrazoles | |
| AU8363398A (en) | Capotasto | |
| AU5688499A (en) | Non-knotting line | |
| AU5112699A (en) | 5-HT1f antagonists | |
| AU4507899A (en) | Substituted n-aryl-o-alkyl-carbamates | |
| AU3204999A (en) | Futureball | |
| AU2609599A (en) | Sensor-coupling | |
| AU4511499A (en) | Substituted cyclooctadepsipeptides | |
| AU2069199A (en) | Codelets | |
| AU5223199A (en) | Bathtub-bathseat | |
| AU1055399A (en) | Rollerboard | |
| AU9347498A (en) | Imidazotriazolopyrimidines | |
| AU3347599A (en) | Aeromobile | |
| AU2840799A (en) | 1-phosphanorbornadienes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |